These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 26385485)
1. Increased Neutrophil-Lymphocyte Ratio Is a Poor Prognostic Factor in Patients with Esophageal Cancer in a High Incidence Area in China. Yutong H; Xiaoli X; Shumei L; Shan S; Di L; Baoen S Arch Med Res; 2015 Oct; 46(7):557-63. PubMed ID: 26385485 [TBL] [Abstract][Full Text] [Related]
2. [Prognostic value of blood neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in patients with gastric cancer]. Li S; Xu X; Liang D; Tian G; Song S; He Y Zhonghua Zhong Liu Za Zhi; 2014 Dec; 36(12):910-5. PubMed ID: 25623765 [TBL] [Abstract][Full Text] [Related]
3. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer? Deng M; Ma X; Liang X; Zhu C; Wang M Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461 [TBL] [Abstract][Full Text] [Related]
4. [Effect of preoperative monocyte-lymphocyte ratio on prognosis of patients with resectable esophagogastric junction cancer]. Zhou WJ; Wu J; Li XD; Wang Q; Ni XF; Jiang JT; Ji M; Wu CP Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):178-183. PubMed ID: 28316215 [No Abstract] [Full Text] [Related]
5. Prognostic value of the neutrophil-to-lymphocyte ratio for overall and disease-free survival in patients with surgically treated esophageal squamous cell carcinoma. Jung J; Park SY; Park SJ; Park J Tumour Biol; 2016 Jun; 37(6):7149-54. PubMed ID: 26662960 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of preoperative platelet-lymphocyte and neutrophil-lymphocyte ratio in patients undergoing surgery for esophageal squamous cell cancer. Xie X; Luo KJ; Hu Y; Wang JY; Chen J Dis Esophagus; 2016 Jan; 29(1):79-85. PubMed ID: 25410116 [TBL] [Abstract][Full Text] [Related]
7. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma. Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Meng YQ; Fu XY; Ma QL; Lin P World J Gastroenterol; 2015 May; 21(18):5591-7. PubMed ID: 25987784 [TBL] [Abstract][Full Text] [Related]
8. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer. Sun X; Liu X; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z Chin J Cancer; 2016 Jun; 35(1):57. PubMed ID: 27342313 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer. Zhao G; Liu N; Wang S; Guo J; Song X; Qi Y; Qiu W; Lv J Medicine (Baltimore); 2020 Mar; 99(10):e19405. PubMed ID: 32150090 [TBL] [Abstract][Full Text] [Related]
10. [Associations of Preoperative Platelet-to-lymphocyte Ratio and Derived Neutrophil-to-lymphocyte Ratio with thePrognosis of Gastrointestinal Stromal Tumor]. Yin XN; Tang SM; Yin Y; Shen CY; Zhang B; Chen ZX Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 48(2):239-243. PubMed ID: 28612534 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma. Zhang Y; Jiang C; Li J; Sun J; Qu X Clin Transl Oncol; 2015 Oct; 17(10):810-8. PubMed ID: 26077119 [TBL] [Abstract][Full Text] [Related]
12. Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab? Ulas A; Avci N; Kos T; Cubukcu E; Olmez OF; Bulut N; Degirmenci M J BUON; 2015; 20(3):714-22. PubMed ID: 26214622 [TBL] [Abstract][Full Text] [Related]
13. Pretreatment neutrophil/lymphocyte ratio but not platelet/lymphocyte ratio has a prognostic impact in multiple myeloma. Li Y; Li H; Li W; Wang L; Yan Z; Yao Y; Yao R; Xu K; Li Z J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27925303 [TBL] [Abstract][Full Text] [Related]
14. [Value of Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio for Prognostic Evaluation of Diffuse Large B-cell Lymphoma]. Ni J; Wang YQ; Zhang YP; Wu W; Zeng QS; Yang MZ; Xia RX Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):427-32. PubMed ID: 27151004 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with stage III and IV colorectal cancer. Kim JH; Lee JY; Kim HK; Lee JW; Jung SG; Jung K; Kim SE; Moon W; Park MI; Park SJ World J Gastroenterol; 2017 Jan; 23(3):505-515. PubMed ID: 28210087 [TBL] [Abstract][Full Text] [Related]
16. Combined neutrophil/platelet/lymphocyte/differentiation score predicts chemosensitivity in advanced gastric cancer. Huang Z; Liu Y; Yang C; Li X; Pan C; Rao J; Li N; Liao W; Lin L BMC Cancer; 2018 May; 18(1):515. PubMed ID: 29720123 [TBL] [Abstract][Full Text] [Related]
17. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis. Yodying H; Matsuda A; Miyashita M; Matsumoto S; Sakurazawa N; Yamada M; Uchida E Ann Surg Oncol; 2016 Feb; 23(2):646-54. PubMed ID: 26416715 [TBL] [Abstract][Full Text] [Related]
18. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab. Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390 [TBL] [Abstract][Full Text] [Related]
19. Neutrophil and Platelet to Lymphocyte Ratios in Associating with Blood Glucose Admission Predict the Functional Outcomes of Patients with Primary Brainstem Hemorrhage. Fan Z; Hao L; Chuanyuan T; Jun Z; Xin H; Sen L; Juan Q; Cao Y; Mu Y World Neurosurg; 2018 Aug; 116():e100-e107. PubMed ID: 29689388 [TBL] [Abstract][Full Text] [Related]
20. The Neutrophil to Lymphocyte Ratio May Predict Benefit from Chemotherapy in Lung Cancer. Liu D; Jin J; Zhang L; Li L; Song J; Li W Cell Physiol Biochem; 2018; 46(4):1595-1605. PubMed ID: 29694985 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]